Blood‐brain barrier transport and brain distribution of morphine‐6‐glucuronide in relation to the antinociceptive effect in rats – pharmacokinetic/pharmacodynamic modelling

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Pharmacology

• Publication date

  2001-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0704406PMID 11739257PMCID PMC1572896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of caffeine and theophylline on nociceptive stimulation in the rat.

  2009cited by this paper
• Modelling of the blood‐brain barrier transport of morphine‐3‐glucuronide studied using microdialysis in the rat: involvement of probenecid‐sensitive transport

  2000influential reference
• Pharmacokinetic-Pharmacodynamic Modelling of Morphine Transport Across the Blood-Brain Barrier as a Cause of the Antinociceptive Effect Delay in Rats—A Microdialysis Study

  2000cited by this paper
• Elevated concentrations of morphine 6‐beta‐D‐glucuronide in brain extracellular fluid despite low blood–brain barrier permeability

  1999influential reference
• Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM.

  1999influential reference
• The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) mice

  1999influential reference
• Methodological Aspects of the Use of a Calibrator in In Vivo Microdialysis–Further Development of the Retrodialysis Method

  1998cited by this paper
• A preliminary study on the distribution of morphine and its glucuronides in the subcompartments of blood.

  1998influential reference
• Delayed antinociceptive effect following morphine‐6‐glucuronide administration in the rat – pharmacokinetic/pharmacodynamic modelling

  1998influential reference
• Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.

  1997cited by this paper
• CONCENTRATION‐EFFECT RELATIONSHIPS OF MORPHINE AND MORPHINE‐6β‐GLUCURONIDE IN THE RAT

  1997cited by this paper
• Disposition and analgesic effects of systemic morphine, morphine-6-glucuronide and normorphine in rat.

  1996influential reference
• Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.

  1996influential reference
• Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates.

  1996influential reference
• Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling.

  1995cited by this paper
• Diffusion of morphine-6-beta-D-glucuronide into the neonatal guinea pig brain during drug-induced respiratory depression.

  1994cited by this paper
• Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats.

  1993cited by this paper
• Quantification of effect delay and acute tolerance development to morphine in the rat.

  1993cited by this paper
• Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate.

  1993cited by this paper
• Comparison of four basic models of indirect pharmacodynamic responses

  1993cited by this paper
• Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.

  1992influential reference
• The in Vivo Study of Drug Action: Principles and Applications of Kinetic-Dynamic Modelling

  1992cited by this paper
• Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.

  1989cited by this paper
• Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.

  1989cited by this paper
• Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.

  1988influential reference
• An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites.

  1988cited by this paper
• Testing computer-controlled infusion pumps by simulation.

  1988influential reference
• Morphine-6-glucuronide, a potent mu agonist.

  1987cited by this paper
• Morphine-6-glucuronide has high affinity for the opioid receptor.

  1987cited by this paper
• Minireview: Multiple MU opiate receptors

  1986influential reference
• Multiple mu opiate receptors.

  1986influential reference
• Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum.

  1981influential reference
• Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

  1980cited by this paper
• Analgesic effect of morphine glucuronides.

  1971influential reference
• Observations on the neuropharmacology of morphine and morphinelike analgesia.

  1960cited by this paper

• Does nonlinear blood-brain barrier transport matter for (lower) morphine dosing strategies?

  2023cites this paper
• Does nonlinear blood-brain barrier transport matter for morphine dosing strategies?

  2023cites this paper
• Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model

  2022cites this paper
• Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development

  2022cites this paper
• In Vitro and In Vivo Sucrosomial® Berberine Activity on Insulin Resistance

  2022cites this paper
• Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances

  2021cites this paper
• The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug‐resistant epilepsy

  2021cites this paper
• Brain microdialysis in neurobiology and neurochemistry

  2020cites this paper
• Основные принципы микродиализа головного мозга и современные возможности его применения в экспериментальной нейробиологии и нейрохимии

  2020cites this paper
• Brain Distribution of Drugs: Pharmacokinetic Considerations.

  2020cites this paper
• Exclusion of unsuitable CNS drug candidates based on their physicochemical properties and unbound fractions in biomatrices for brain microdialysis investigations.

  2019cites this paper
• Molecular docking analysis of phytoconstituent from Momordica charantia with Guanylate Cyclase catalytic domain

  2018cites this paper
• Opioids and the Blood-Brain Barrier: A Dynamic Interaction with 
Consequences on Drug Disposition in Brain

  2017cites this paper
• Microdialysis as an Important Technique in Systems Pharmacology—a Historical and Methodological Review

  2017cites this paper
• Development of hysteresis analysis as a model-independent approach to assess temporal dissociation in pharmacokinetics and pharmacodynamics

  2016influential citation
• [Drug glucuronidation and disposition in brain].

  2016cites this paper
• BDNF Pretreatment Attenuates Morphine-Induced Learning and Memory Impairment in Rats

  2015cites this paper
• A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain.

  2015cites this paper
• Pharmacokinetic Concepts in Brain Drug Delivery

  2014cites this paper
• Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

  2014cites this paper
• Drug Discovery Methods for Studying Brain Drug Delivery and Distribution

  2014cites this paper
• Opioid receptor bronchial tree: current science

  2014cites this paper
• The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication

  2014cites this paper
• PKPD Aspects of Brain Drug Delivery in a Translational Perspective

  2014cites this paper
• Translational Approaches for Predicting CNS Drug Effects Using Microdialysis

  2013cites this paper
• Effect of 12‐oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6‐glucuronide in Wistar rats

  2013cites this paper
• Physiologically Based Pharmacokinetic Modelling of Drug Penetration Across the Blood–Brain Barrier—Towards a Mechanistic IVIVE-Based Approach

  2013influential citation
• Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone.

  2012cites this paper
• Integration of PBPK and Pharmacodynamics

  2012cites this paper
• Morphine metabolism, transport and brain disposition

  2011cites this paper
• [Blood-brain barrier transport of opioid analgesics].

  2011cites this paper
• Determination of the sevoflurane sparing effect of methadone in cats.

  2011cites this paper
• How to measure drug transport across the blood-brain barrier

  2011cites this paper
• Strong opioids in cancer pain : clinical and pharmacogenetic factors influencing an individual's response to morphine and oxycodone

  2010cites this paper
• The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study

  2010cites this paper
• An investigation into the distribution and concentration of drugs of abuse within different body compartments and relationship with toxicity

  2010cites this paper
• Convulsant activity and pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats.

  2010cites this paper
• Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?

  2010cites this paper
• A farmacocinética da metadona e seus efeitos antinociceptivos, comportamentais e sobre a concentração alveolar mínima de sevofluorano em felinos

  2010cites this paper
• Effect of bile salts on drug delivery to the brain

  2010cites this paper
• Assessment of pharmackinetics and pharmacodynamics of psychoative drugs using brain microdialysis.

  2010cites this paper
• Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.

  2010cites this paper
• Methodologies to assess brain drug delivery in lead optimization.

  2009cites this paper
• Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3‐ and 6‐glucuronide in the human brain *

  2009cites this paper
• The Role of the Blood-Brain Barrier

  2009cites this paper
• Do morphine and its metabolites morphine-6-glucuronide and morphine-3-glucuronide affect dopamine release in nucleus accumbens in mice?

  2009cites this paper
• Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept

  2009cites this paper
• Development of a High-Throughput Brain Slice Method for Studying Drug Distribution in the Central Nervous System

  2009cites this paper
• Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid

  2009cites this paper
• Pharmacokinetics of buprenorphine following intravenous administration in dogs.

  2008cites this paper
• Morphine‐6‐glucuronide (M6G) for postoperative pain relief

  2008cites this paper
• Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic‐pharmacodynamic modelling approach

  2008cites this paper
• Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.

  2007cites this paper
• Genetic variability and opioid efficacy

  2007cites this paper
• In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular Fluids

  2007cites this paper
• Population pharmacokinetic modelling of non‐linear brain distribution of morphine: influence of active saturable influx and P‐glycoprotein mediated efflux

  2007cites this paper
• Intracerebral microdialysis technique and its application on brain pharmacokinetic-pharmacodynamic study

  2007cites this paper
• Integrated Pharmacokinetics and Pharmacodynamics in Drug Development

  2007cites this paper
• 3. MODELLING OF BIOPHASE DISTRIBUTION OF MORPHINE IN VIVO

  2007cites this paper
• On The Rate and Extent of Drug Delivery to the Brain

  2007cites this paper
• Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.

  2007cites this paper
• Blood–brain distribution of morphine‐6‐glucuronide in sheep

  2006influential citation
• A PHARMACOKINETIC STUDY OF DIPHENHYDRAMINE TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER IN ADULT SHEEP: POTENTIAL INVOLVEMENT OF A CARRIER-MEDIATED MECHANISM

  2006cites this paper
• Morphine-6-Glucuronide: Morphine's Successor for Postoperative Pain Relief?

  2006cites this paper
• Pharmacokinetic Consequences of Active Drug Efflux at the Blood–Brain Barrier

  2006cites this paper
• Mechanism-based Pharmacokinetic–Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine in Healthy Volunteers

  2006cites this paper
• Role of morphine's metabolites in analgesia: Concepts and controversies

  2006cites this paper
• In vitro prediction of brain penetration – a case for free thinking?

  2006cites this paper
• Application of microdialysis for pharmacokinetic-pharmacodynamic modelling

  2006cites this paper
• Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.

  2006cites this paper
• Chapter 6.4 Microdialysis as a method to study blood-brain barrier transport mechanisms

  2006cites this paper
• Chapter 6.6 Microdialysis for characterization of PK/PD relationships

  2006cites this paper
• Neuropharmacokinetics of a new AMPA modulator, S18986, in the rat

  2006influential citation
• Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling—A New Classification of Biomarkers

  2005cites this paper
• Genetic variability and clinical efficacy of morphine

  2005cites this paper
• Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling

  2005cites this paper
• Influence of probenecid on the delivery of morphine-6-glucuronide to the brain.

  2005cites this paper
• Morphine‐6‐glucuronide: Actions and mechanisms

  2005influential citation
• Distribution of the Novel Antifolate Pemetrexed to the Brain

  2005influential citation
• NEUROPHARMACOKINETICS OF A NEW α-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONIC ACID (AMPA) MODULATOR, S18986 [(S)-2,3-DIHYDRO-[3,4]CYCLOPENTANO-1,2,4-BENZOTHIADIAZINE-1,1-DIOXIDE], IN THE RAT

  2005cites this paper
• Randomized, Double-blind Study of the Analgesic Efficacy of Morphine-6-Glucuronide versus Morphine Sulfate for Postoperative Pain in Major Surgery

  2005cites this paper
• On-line desalting and determination of morphine, morphine-3-glucuronide and morphine-6-glucuronide in microdialysis and plasma samples using column switching and liquid chromatography/tandem mass spectrometry.

  2005cites this paper
• Simultaneous central nervous system distribution and pharmacokinetic–pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats

  2004cites this paper
• Blood-Brain Barrier Transport of Drugs Across Species with the Emphasis on Health, Disease and Modelling

  2004cites this paper
• Microdialysis in drug discovery.

  2004cites this paper
• Population Pharmacokinetic Modeling of Blood-Brain Barrier Transport of Synthetic Adenosine A1 Receptor Agonists

  2004cites this paper
• Genetyka a opioidy. Nowe dane pozwalające na lepsze zrozumienie analgezji opioidowej

  2004cites this paper
• The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.

  2004cites this paper
• Pharmacokinetic and pharmacodynamic evaluation of intravenous hydromorphone in cats.

  2004cites this paper
• An Integrated Model for the Analysis of Pharmacokinetic Data from Microdialysis Experiments

  2004cites this paper
• Pharmacokinetic-Pharmacodynamic Modeling of Morphine-6-glucuronide-induced Analgesia in Healthy Volunteers: Absence of Sex Differences

  2004cites this paper
• Beta-phenylethylamines and the isoquinoline alkaloids.

  2003cites this paper
• Characterization of the pharmacokinetics, brain distribution, and therapeutic efficacy of the adenosine A1 receptor partial agonist 2'-deoxy-N6-cyclopentyladenosine in sarin-poisoned rats.

  2003cites this paper
• Pharmacodynamic Effect of Morphine-6-glucuronide versus Morphine on Hypoxic and Hypercapnic Breathing in Healthy Volunteers

  2003cites this paper
• Evidence for an active transport of morphine‐6‐β‐d‐glucuronide but not P‐glycoprotein‐mediated at the blood–brain barrier

  2003cites this paper
• Different distribution of morphine and morphine‐6β‐glucuronide after intracerebroventricular injection in rats

  2003cites this paper
• Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effect of Norfloxacin in Rats

  2003cites this paper
• Temporal relationship of hippocampal liquor- and plasma-cortisol-concentrations in the domestic pig challenged with synthetical adreno-corticotrophic hormone.

  2002cites this paper
• Increased CNS uptake and enhanced antinociception of morphine‐6‐glucuronide in rats after inhibition of P‐glycoprotein

  2002influential citation